Therapeutic innovations in endocrine diseases – Part 1: New medical treatments for chronic excess of endogenous cortisol (Cushing's syndrome) - 16/06/16
Doi : 10.1016/j.lpm.2016.05.006
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Summary |
Diverse hormonal, antisecretory, antitumoural or immunomodulatory therapeutic innovations act for broadening the management scope of adrenal, pituitary and endocrine tumours.
In this issue
Innovations in autoimmune diseases
L. Guillevin, France
Stem cell transplantation and mesenchymal cells to treat autoimmune diseases
A. Tyndall, Switzerland, and J.M. van Laar, Netherlands
New therapeutic approaches for ANCA-associated vasculitides
B. Chaigne, L. Guillevin, France
New therapeutic approaches in rheumatoid arthritis
R.F. van Vollenhoven, Sweden
Future treatments for Sjögren's syndrome
J.-O. Pers, A. Saraux, France
Therapeutic innovations in endocrine diseases: part 1: new medical treatments for chronic excess of endogenous cortisol (Cushing's syndrome)
X. Bertagna, France
Therapeutic innovations in endocrine diseases: part 2: modified-release glucocorticoid compounds: what good do they provide to the adrenal insufficient patient?
Y. Reznik, France
Therapeutic innovations in endocrine diseases: part 3: temozolomide and future therapeutics for aggressive pituitary tumors and carcinomas
H. Lasolle, G. Raverot, France
Therapeutic innovations in endocrine diseases: part 4: pasireotide: long-acting release somatostatin analogue
J.-L. Wémeau, France
Therapeutic innovations in endocrine diseases: part 5: rituximab and graves’ orbitopathy
M. Ladsous, France
Plan
© 2016
Elsevier Masson SAS. Tous droits réservés.
Vol 45 - N° 6P2
P. e201-e204 - juin 2016 Retour au numéro
Article précédent
- Future treatments for Sjögren's syndrome
- Jacques-Olivier Pers, Alain Saraux
- Therapeutic innovations in endocrine diseases – Part 2: Modified-release glucocorticoid compounds: What good do they provide to the adrenal insufficient patient?
- Yves Reznik
Bienvenue sur EM-consulte, la référence des professionnels de santé.